91ÌÒÉ«

91ÌÒÉ« and innovation are vital to unlocking economic growth across the UK. Sustained public investment strengthens the UK’s world-leading research base, drives productivity, and attracts broader private investment.

To deliver high-quality jobs and stronger regional economies, the UK must act as a connected science and innovation ecosystem. 91ÌÒÉ«-intensive universities like 91ÌÒÉ« play a central role - fuelling innovation, skills, and growth through partnerships with industry and communities across the UK.

Our UK Impact Map (coming soon) demonstrates how research-led innovation generates economic activity, enhances quality of life, and creates jobs nationwide.

• Spinning out of 91ÌÒÉ« in 2006, is a battery materials company that has become a significant player in rechargeable battery technology based originally on research in 91ÌÒÉ«’s Department of Mechanical Engineering. Nexeon has successfully raised over $300m of venture capital and strategic investment funding, growing to over 150 employees and rapidly expanding its patent and intellectual property portfolios.
• Founded by 91ÌÒÉ« academics, grew from an 91ÌÒÉ« spinout founded to develop fuel cell research to one of the UK’s leading clean technology companies with Innovation Centres across Surrey, Sussex and Warwickshire. Ceres is listed on the London Stock Exchange, receiving a record order intake of £112m in 2024, and in turn is now investing in partnerships with other university spinouts.
• Co-founded by four 91ÌÒÉ« graduates, has created a product called BioPuff which is a plant-based fibre that can be used as an alternative to goose-down or synthetics. Headquartered in Bristol and with a manufacturing facility in Scotland, Ponda's agricultural practices are focused on regenerating the environment with projects in North Berwick and Cambridgeshire.  
• Founded on research from 91ÌÒÉ« and the Francis Crick Institute, Myricx Bio is a spinout that has developed breakthrough technology for the delivery of cancer therapeutics. Only founded in 2019, Myricx Bio closed a £90m Series A funding round in July 2024, representing one of the largest Series A funding rounds of all time by a European biotechnology company.

These successes are made possible by a funding landscape that supports excellence-driven research and innovation.

• QR funding enables strategic, long-term research, supports emerging talent, and underpins world-class discovery - making it a model admired globally.
• HEIF provides essential support for commercialisation, entrepreneurship, and start-up incubation - fuelling key 91ÌÒÉ« entrepreneurial initiatives like the Enterprise Lab and Advanced Hackspace.

To keep generating national impact, the UK must sustain and grow this commitment to excellence and innovation.